Skip to main content
. 2017 Mar 18;8(19):31601–31611. doi: 10.18632/oncotarget.16364

Table 1. Patient characteristics of the asthma patients included in this study.

Gender Age [years] FEV1 [%pred] Atopy Concomitant medication
Male 41 81.1 Yes ICS, SABA
Female 22 96.6 Yes None
Female 24 101.1 Yes ICS, LABA
Male 25 102.5 Yes None
Female 19 115.9 Yes ICS, SABA
Female 25 79.8 Yes None
Female 25 96.3 Yes None
Female 26 102.5 Yes ICS, SABA
Female 32 101.5 Yes ICS

Spirometry data was obtained without administration of bronchodilators.

FEV1, forced expiratory volume in 1s; ICS, inhaled corticosteroids; LABA, long-acting beta-adrenoceptor agonist; SABA, short-acting beta-adrenoceptor agonist.